Ondansetron

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70518-3512
  • Package NDC 70518-3512-0
  • Package NDC 70518-3512-1
  • Package NDC 70518-3512-2
  • Package NDC 70518-3512-3
  • Package NDC 70518-3512-4
  • Package NDC 70518-3512-5
  • Package NDC 70518-3512-7
  • Package NDC 70518-3512-8
  • Application number ANDA078152
  • SPL ID 5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e
  • SPL set ID c0d827d0-333f-4187-ac75-9dc7d34b6169
  • UNII 4AF302ESOS
  • RxCUI 104894

What the source publishes

Labeler
REMEDYREPACK INC.
Active ingredients
Ondansetron
Form
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70518-3512_5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e
{
  "name": "Ondansetron",
  "splId": "5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e",
  "labels": [
    {
      "setId": "c0d827d0-333f-4187-ac75-9dc7d34b6169",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0d827d0-333f-4187-ac75-9dc7d34b6169",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0d827d0-333f-4187-ac75-9dc7d34b6169"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "REMEDYREPACK INC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)",
      "package_ndc": "70518-3512-0",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220907"
    },
    {
      "sample": false,
      "description": "6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)",
      "package_ndc": "70518-3512-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220929"
    },
    {
      "sample": false,
      "description": "10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-2)",
      "package_ndc": "70518-3512-2",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231020"
    },
    {
      "sample": false,
      "description": "20 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-3)",
      "package_ndc": "70518-3512-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231031"
    },
    {
      "sample": false,
      "description": "12 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-4)",
      "package_ndc": "70518-3512-4",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231120"
    },
    {
      "sample": false,
      "description": "9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)",
      "package_ndc": "70518-3512-5",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231223"
    },
    {
      "sample": false,
      "description": "15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)",
      "package_ndc": "70518-3512-7",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250306"
    },
    {
      "sample": false,
      "description": "3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)",
      "package_ndc": "70518-3512-8",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250724"
    }
  ],
  "productId": "70518-3512_5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e",
  "useDomain": "unknown",
  "dosageForm": "TABLET, ORALLY DISINTEGRATING",
  "productNdc": "70518-3512",
  "deaSchedule": null,
  "genericName": "Ondansetron",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ONDANSETRON",
      "strength": "4 mg/1"
    }
  ],
  "applicationNumber": "ANDA078152",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220907",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175817",
      "N0000175818"
    ],
    "unii": [
      "4AF302ESOS"
    ],
    "rxcui": [
      "104894"
    ],
    "spl_set_id": [
      "c0d827d0-333f-4187-ac75-9dc7d34b6169"
    ],
    "pharm_class_epc": [
      "Serotonin-3 Receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Serotonin 3 Receptor Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "REMEDYREPACK INC."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70518-3512_5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e"